© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefquinome Sulfate grabbed the attention of the pharmaceutical world in the late twentieth century, emerging as a fourth-generation cephalosporin antibiotic with roots in the search for broader-spectrum drugs that could take on both Gram-positive and Gram-negative bacteria. European researchers recognized early the growing resistance challenge on livestock farms and pushed forward to develop molecules that reached deeper and lasted longer inside animals. Antibiotics like cefquinome didn’t appear out of thin air—they resulted from decades of hard work in organic chemistry labs, where trial and error were a daily routine. The moment cefquinome made its way to market, it symbolized a shift: science could outpace bacterial adaptation, for a time at least. Since then, commercial production has grown, closely tracked by public health authorities, veterinarians, and food safety agencies alike.
Cefquinome Sulfate isn’t just a compound hidden in a pharmaceutical catalog. It’s the backbone of several injectable formulations widely used in veterinary medicine—especially on cattle and swine farms. Farmers turn to this product when a herd faces severe mastitis or respiratory outbreaks. Hospitals rarely see it, but on farms it becomes a lifeline for sick animals that might otherwise succumb to infections. Companies manufacture it as a sterile powder, packed in vials to be reconstituted before injection, allowing veterinarians to adjust dosing as animals gain weight or new cases emerge in the barn. The broad spectrum of activity and effectiveness against especially tough organisms makes it a drug of last resort in some agricultural circles, a responsibility not taken lightly.
Cefquinome Sulfate shows up in the lab as a white or almost white crystalline powder. It dissolves in water but remains fairly stable in neutral pH ranges, which comes in handy for long shelf life. Chemists note its molecular formula as C24H24N6O5S2·H2SO4, featuring a characteristic β-lactam ring linked to a sophisticated dihydrothiazine ring system that’s key to its action. The sodium salt form allows it to dissolve easily for injection, which keeps application fast on busy farms. Few compounds match its dual resistance to β-lactamase enzymes and physical stability at room temperature, critical factors that supported its approval in different regions.
Regulations around cefquinome labeling run strict. Dosage strengths get listed down to the milligram, with withdrawal periods for both milk and meat printed clearly on every package. These warnings stem not only from health agencies but also from international trade rules that don’t tolerate residues in exported products. Labeling calls out batch numbers, expiry dates, storage conditions (usually below 25°C and protected from light), giving users no excuse for mishandling. Product inserts outline clinical indications—respiratory tract infections, mastitis, foot rot—and contraindications like use in animals with β-lactam allergies. Countries often enforce site-specific labeling, so veterinarians and farm staff stay alert to the smallest details.
Producing cefquinome sulfate starts with the synthesis of the cephalosporin core, followed by stepwise modifications to introduce specific side chains conferring its unique activity. Process engineers set up multiple purification stages, from filtration to crystallization, to strip out byproducts and guarantee pharmaceutical-grade quality. The final salt formation with sulfuric acid yields the water-soluble powder veterinarians rely on. This method requires constant quality checks—thin-layer chromatography, HPLC, and spectroscopy feature heavily in batch release testing, since the integrity of every gram matters for the antibiotic’s safety and performance.
Cefquinome’s core structure supports only limited modifications, as changes to the β-lactam ring usually destroy antibiotic activity. Researchers found their path tweaking the substituents at position 7 or 3 of the cephalosporin nucleus, balancing antimicrobial activity and pharmacokinetics. Most of the ongoing research focuses less on changing the molecule itself and more on improving delivery forms—depot suspensions, microsphere encapsulation, or even inhaled products for large animal use. Stability in plasma and resistance to deactivation by animal enzymes keep cefquinome at the top tier of injectable antibiotics, with only marginal improvements expected from tweaks in its structure.
Pharmacologists and veterinarians call cefquinome by several names depending on the brand and market. Synonyms include CS, BA-1236, and cefquinome sulfate, though the INN (International Nonproprietary Name) remains cefquinome. Marketed names range from Cobactan to Cequinit, varying by geographic region and marketing agreements. This variety in naming can make it hard for farmers to keep track of identical products sold under different labels, reinforcing the need for pharmacists and veterinarians to double-check substance names before dispensing.
Handling cefquinome sulfate requires careful adherence to safety protocols. Lab staff and veterinarians wear gloves, face protection, and lab coats to prevent occupational exposure, since allergic reactions can occur in sensitive individuals. Sharps disposal, proper reconstitution with sterile water, and immediate use after mixing cut down contamination risk in high-throughput veterinary clinics. Disposal of expired or unused product follows hazardous waste guidelines to prevent antibiotic residues from entering waterways—an issue that gets attention from environmental groups and public health authorities. In the field, proper training ensures the right animal gets the right dose at the right time, minimizing the risk of resistance while protecting food safety.
Cefquinome sulfate earns its keep across the livestock industry, especially where bacteria like Escherichia coli, Streptococcus uberis, Actinobacillus pleuropneumoniae, or Staphylococcus aureus run rampant. Dairy farms use it for mastitis cases stubborn against older antibiotics. Swine operations consider it indispensable for outbreaks of respiratory disease that threaten an entire herd’s productivity. Even in horses, cefquinome can play a role in severe bacterial infections, though it comes at a higher cost. Most countries limit its sale and distribution to licensed veterinarians, acknowledging the serious consequences of misuse—both for animal welfare and public health.
Current research tracks two main areas: monitoring resistance and searching for better formulations. Agricultural universities study patterns of cefquinome resistance and make public databases tracking outbreaks and strain susceptibility. Pharmaceutical laboratories look for ways to extend shelf life, boost solubility, or reduce the frequency of dosing, making treatments more effective and less stressful on animals. Field trials often compare cefquinome to older antibiotics or mix it into integrated protocols that combine vaccines, improved hygiene, and targeted treatment. Funding for this work increasingly comes from both government research grants and private companies, hoping to secure a market advantage by being the first to address emerging challenges.
Most toxicity studies focus on two questions: How safe is cefquinome for the treated animal, and what are the risks if residues enter the human food chain? Trials in cattle, swine, and laboratory rodents typically show a wide margin of safety when given at recommended doses. Acute reactions like allergies appear rarely but do prompt strict reporting and follow-up. Chronic exposure risks for humans sit at the center of regulatory concern, driving strict withdrawal times and regular screening of milk and meat. Environmental fate also factors in—all antibiotics used on farms risk ending up in wastewater, which can drive the development of resistant bacteria in the broader ecosystem. This issue fuels debate at food safety meetings and underscores the responsibility resting on everyone using or manufacturing these drugs.
Cefquinome sulfate faces an uncertain future. On one hand, veterinarians and livestock producers rely on it to save animals and keep farms productive. On the other hand, global health authorities warn that continued use—especially outside strict guidelines—could breed resistance that crosses over into human medicine. Future solutions may come from integrated pest management, more precise use of diagnostics on farms, and the arrival of entirely new antibiotic classes. Research into alternatives, like vaccines or bacteriophage therapy, ramps up as regulators tighten rules in an effort to keep critical drugs effective. No single actor can solve the problem alone; farmers, veterinarians, manufacturers, and government agencies share the burden of stewarding this and other antibiotics for the decades ahead.
Cefquinome sulfate pulls its weight as a fourth-generation cephalosporin antibiotic, designed for use in veterinary medicine. You’ll find this drug showing up in the toolkit of veterinarians treating livestock, especially cattle, pigs, and, less often, horses. Unlike your garden-variety antibiotics, this one packs a punch against a broad group of harmful bacteria, including some that have learned to shrug off older drugs.
Farm animals face plenty of health hazards. From bacteria in dirty bedding to close-quarters living, infections can race through a herd or flock. Mastitis, pneumonia, and septicemia tear through cattle and pigs fast, with potentially serious knock-on effects for farms and food supply. In these situations, stubborn bacteria bring economic strain and animal suffering.
My uncle raised dairy cows for over two decades. He could spot mastitis before many younger farmers would have noticed. Yet, even with sharp eyes, treatments sometimes failed—antibiotics that worked the year before fell flat as bacteria developed resistance. Drugs like cefquinome sulfate offer a vital backup for those tough cases, especially as bacteria outsmart older medications.
Cefquinome sulfate shouldn’t show up in every case of sniffles or fever. Vets turn to this drug when more typical antibiotics can’t pin down the infection or when quick, decisive action stands between recovery and bigger losses. A rapid, targeted strike helps cut down the spread, sparing both animals and people from more long-term problems.
Here’s the catch: antibiotics, used without care, let bacteria find chinks in the armor. Overusing broad-spectrum tools—especially strong ones like cefquinome—can help resistant bacteria multiply. Animal medicine and human health cross paths on this point. Resistant bugs in animals don’t always stay on the farm; through meat, milk, or even handling, people pick up these bacteria, shrinking our options for treating illness.
The World Health Organization views antibiotics like this one as “critically important,” underlining that overuse puts more than animals at risk.
Protection against resistance starts at the ground level. Farms do best sticking to tough hygiene standards, keeping barns clean, and tackling problems early so infections don’t spiral. Vaccinating animals further shrinks the need for powerful treatments. When infections do break out, good records let vets figure out which drugs worked before, and which to save for emergencies.
In my experience, honest conversations between vets and farmers matter more than protocols pasted on the barn wall. When trust runs high, no one jumps straight to the “big guns.” In clinics, rapid bacterial testing tells vets whether cefquinome sulfate fits the job or if a lighter touch will do.
No magic pill keeps farm animals healthy, but using antibiotics right gives us breathing room. Cefquinome sulfate helps treat sick animals, keeps farms productive, and supports safe food supplies. That value only lasts if farmers and vets treat medicines as tools—not shortcuts—always weighing animal health against risks to people. Good science, honest advice, and learning from experience keep the balance in check.
Cefquinome sulfate stands out as a powerful antibiotic developed for animals, not people. Farms and veterinary clinics make good use of it, especially for livestock where disease spreads quickly and a bacterial infection means real money lost and animal suffering. Cattle and pigs benefit the most from cefquinome sulfate. This drug fights off tough bacteria that cause life-threatening diseases in food-producing animals. It’s a fourth-generation cephalosporin, so it handles bacteria that other drugs can’t touch.
Cattle, both beef and dairy, face regular battles against respiratory infections and mastitis. Farmers have seen firsthand how quickly a cow can go from eating grain to lying in a corner, milk production plummeting and quality dropping. Cefquinome steps in at this point, with veterinarians reaching for it to tackle tricky infections like E. coli mastitis or severe pneumonia in calves and adults. It acts fast, which cuts down the time cows spend off-feed and gets them up and producing again. Studies back this up, showing improved cure rates and less disease spread inside herds.
Pig producers use cefquinome to fight off infections—Swine Dysentery and bacterial pneumonia rank high on the list. Anyone who’s worked with growing pigs knows how fast sickness can sweep through a barn. The drug’s injectable form makes it easier to get sick animals back on their feet, especially those too weak to eat or drink. Fewer deaths, less suffering, and better weight gain all follow. This has ripple effects on food security, farm income, and animal welfare.
Sheep and goats sometimes get treated with cefquinome, though not as widely as cattle and pigs. The same holds for horses—vets sometimes use cefquinome for joint or wound infections when usual antibiotics fail. The drug doesn’t see much use in pets like dogs and cats. Most veterinarians choose other, less critical antibiotics, since cefquinome’s strength sits best where resistance issues really threaten the food chain.
Nobody likes seeing an animal suffer, least of all the people who raise them. The tools in the veterinary toolbox have limits. Resistance grows when every infection gets hit with the strongest antibiotic, so responsible use decides how long these drugs keep working. In some places, regulations keep cefquinome reserved for cases where nothing else works. This preserves effectiveness and keeps resistant bacteria out of the meat and milk that end up at grocery stores.
Safeguarding animal health runs hand in hand with ensuring safe food. That’s become clear as more consumers ask tough questions about antibiotic use in agriculture. Science backs up the need for careful oversight, real-time tracking, and training among vets and farmers. Monitoring programs in the EU and US gather data on antibiotic residues and resistance trends, showing progress and risks side by side.
Education makes the biggest difference. Veterinarians share responsibility with farmers to make smart treatment decisions. Accurate diagnosis, targeted therapy, and using laboratory results help reduce unnecessary treatments. Good animal husbandry—clean barns, vaccinations, proper feed—lowers disease risk before antibiotics ever come into play. Ongoing investment in research means better guidance on when to use drugs like cefquinome and how to track resistance patterns. Policy, practice, and public awareness all play a role in keeping both animals and food systems safe.
Cefquinome sulfate comes up a lot on the farm. It’s a fourth-generation cephalosporin antibiotic, which puts it in a class known for treating bacterial infections in livestock—mainly cattle, pigs, and sometimes horses. The drug targets some stubborn bacteria that easily resist older antibiotics; it disrupts their cell walls, stopping infections before things get out of hand. When animals fall ill with respiratory or mammary infections, or they pick up a nasty post-surgical bug, this medicine steps up. Resistance to older cephalosporins forces many veterinarians to consider this antibiotic after trying alternatives.
Farm life doesn’t always run by the book, but medicine can’t afford guesswork. The set dosage for cefquinome sulfate depends most on the animal’s species, weight, and the particular infection. In cattle facing respiratory illness, most veterinary references guide toward a dose of 1 mg cefquinome per kg of body weight, injected once daily for three to five days. For mastitis in dairy cows, the approach often uses an intramammary infusion with a set mg amount per quarter, usually over a short stretch of consecutive days.
In pigs, when treating things like bacterial pneumonia, the suggested dose commonly runs at 2 mg per kg by intramuscular injection, again once daily, generally for three days. Horses rarely need this drug, but in those rare cases, guidance comes straight from a vet.
Trying to stick to these guidelines matters. Underdosing might leave infections lingering and overuse only fuels antibiotic resistance—a growing nightmare for both vets and farmers. Plenty of people I know in farming, myself included, have seen the consequences when animals don’t complete an antibiotic course or are treated at the wrong strength. In those cases, the infection hangs around or comes back, hitting herd health and farm profits.
Misusing strong antibiotics like cefquinome can ripple out far beyond the barn. Bacteria that survive sloppy treatment get smarter, sapping the medicine’s power for the next time. People also rely on similar drugs—so when resistance builds on the farm, it threatens human health. International watchdogs, such as the World Health Organization and the World Organisation for Animal Health, have put tight rules on these medications because of this rising global concern.
In my years around agriculture, I’ve watched veterinarians double-check weights and measure doses carefully because the stakes keep getting higher. One wrong calculation erodes both animal welfare and public trust. The real world can be messy—animals don’t always line up neatly for weighing—but taking the extra step is worth it every time.
Keeping antibiotics working into the future means building safe habits now: weigh animals for each dose, avoid cutting corners, and listen to professional advice. Strict withdrawal periods after dosing safeguard milk and meat supplies; skipping that wait puts the public at risk. I know how tempting it can be to rely on experience or gut feeling, especially in an emergency, but evidence and veterinary instruction have to come first.
Cefquinome sulfate works best when it’s part of a careful plan, not a quick fix. Animals heal, drug resistance slows down, and everyone benefits when dosing follows the numbers, not guesswork. Real stewardship comes down to these day-to-day details.
Cefquinome sulfate isn’t a name you hear every day, unless you spend your time around farm animals or work in a veterinary clinic. This antibiotic belongs to the so-called fourth-generation cephalosporins, drugs built to fight off some of the nastiest bacteria that turn up in livestock like cows and pigs. The idea behind using cefquinome is sound—treat the infection, help the animal recover, protect food production, and keep herds healthy. That doesn’t mean people should rush in without a second thought.
Using cefquinome in animals can bring more than smooth recoveries. Just as with other antibiotics, there’s a risk of reactions. Some cows or pigs might get local swelling, pain, or redness where the drug gets injected. On rare occasions, an animal may stumble into trouble with diarrhea, reduced appetite, and even allergic symptoms like trouble breathing or swelling. These signs are a signal to take notice—they point to the fact that even tried-and-true medications can surprise you.
I’ve seen a few farmers caught off guard when animals develop sores or stop eating after a round of antibiotics. That’s not exactly a small concern, especially on farms where margins hang tight and every animal counts. Beyond those individual reactions, misuse or careless routine use can stack up trouble for everyone.
There’s a bigger picture: the risk of antibiotic resistance. The World Health Organization and other experts talk straight about this. When strong drugs like cefquinome get used without checks, bacteria can learn to fight back. Resistant bugs don’t stick to barn doors—they show up in people too. Data from European health agencies confirm that overuse of antibiotics in animals links to tougher bacteria in humans. Stories of stubborn infections in hospitals make this issue real for folks outside agriculture.
On the food side, leftover bits of cefquinome can find their way into meat or milk if farmers ignore withdrawal times. Regulatory agencies like the FDA and EMA insist on keeping these residues in check, setting strict limits to keep the food supply safe. But mistakes or rushed decisions can still bring risk.
It doesn’t help to keep this conversation locked in veterinary circles. Farmers, vets, drug makers, and regulators should work together, keeping the focus on responsible antibiotic use. I’ve watched vets push for more lab tests before reaching for the syringes. That way, treatments go to the animals who need it, and the spread of resistance gets slowed down. Every year, more farms switch to herd health plans that build up immunity and spot problems early. Less medicine, more prevention.
Transparency matters. Open records, honest labels, and ongoing training for anyone handling medications strengthen food safety and animal welfare. People buying meat and milk deserve to know how animals are raised. Plus, regular checks remind everyone that medicines, even the powerful ones, are double-edged swords.
Cefquinome sulfate pulls its weight when used carefully. Side effects don’t just affect a single animal—they ripple out to wider concerns about food safety and global health. Tackling these risks takes discipline and a willingness to keep improving the way antibiotics are used on the farm. That’s where real security for animals and people lies.
Cefquinome sulfate plays a crucial role in treating bacterial infections in animals, especially in cattle, pigs, and other livestock. As a fourth-generation cephalosporin antibiotic, it brings powerful action against a wide range of bacteria that harm farm animals. Vets rely on this drug when other antibiotics no longer work or when a particularly nasty infection strikes. It’s tough stuff—both a blessing and a risk.
Letting anyone buy antibiotics like cefquinome without a prescription poses real dangers. Overuse or misuse leads to antibiotic resistance. Farms where workers skip the vet and grab whatever medication is at hand often end up dealing with bacteria that don’t respond to treatment anymore. This isn’t just a problem for animals. Resistant bacteria can jump to humans, through food or direct contact. Studies from the World Health Organization and the U.S. Centers for Disease Control show a clear link between misuse on farms and resistance problems in hospitals.
I grew up in a farming community. We trusted our local vet to know which medicine fit which situation. Some neighbors tried to skip appointments, wanting quick fixes with leftover antibiotics. Word spread through our town of cattle that didn’t recover, or infections running wild in barns. Every time an antibiotic got used without careful guidance, it seemed to lose its punch the next year. Watching that taught me the value of gatekeeping with these drugs. That lesson came not from a textbook, but from the pocketbook and heartache of lost livestock.
A prescription acts as more than a piece of paper. It keeps antibiotics from becoming cattle feed supplements or general immune-boosters. A vet knows which cases suit cefquinome, checks for allergies, weighs the chance of side effects, and warns about proper withdrawal times so residues don’t land in the food supply. Without such checks, antibiotic residues can get into milk, meat, and water, creating a ripple effect on families, communities, and the environment.
On top of that, keeping cefquinome behind the prescription counter helps track use, spot abuse, and signal if a certain infection seems to be getting out of hand nationally. Surveillance matters—a lot—when the tools to fight disease begin to fail.
Country after country has tightened up access to antibiotics like cefquinome. Some places go further, requiring official documentation for every dose given. The balance between animal welfare and public safety calls for smart regulation. Education helps, too. Farmers who learn the risks of overuse tend to respect prescriptions more, treating them less as barriers and more as safety nets.
Following responsible practices, governments and industry leaders can create better systems for reporting, auditing, and training. Vets can stay up to date with resistance trends, and regulators can pull products faster when things go wrong.
People often forget where their steak, milk, or eggs start. Choices about medicines on the farm affect more than a single farm family. Drug-resistant bugs don’t respect fences or borders. Requiring a prescription for cefquinome isn’t only about stopping a few irresponsible folks. It’s about keeping food safer, animals healthier, and communities resilient against a threat that no one can see until it’s already there.
| Names | |
| Preferred IUPAC name | cefquinome sulfate |
| Other names |
Cefquinome Cefquinomum Cefquinome sulfate |
| Pronunciation | /sefˈkwɪn.oʊm ˈsʌl.feɪt/ |
| Identifiers | |
| CAS Number | [120138-19-2] |
| Beilstein Reference | 3468270 |
| ChEBI | CHEBI:77985 |
| ChEMBL | CHEMBL2106027 |
| ChemSpider | 5018355 |
| DrugBank | DB11470 |
| ECHA InfoCard | 100.231.848 |
| EC Number | 64221-86-9 |
| Gmelin Reference | 11338861 |
| KEGG | Cefquinome Sulfate KEGG: **D07655** |
| MeSH | D000077297 |
| PubChem CID | 6918495 |
| RTECS number | XN8060000 |
| UNII | 7J9Y4VD66E |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C24H24N6O5S2·H2SO4 |
| Molar mass | 636.7 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.69 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -2.17 |
| Acidity (pKa) | 2.6 |
| Basicity (pKb) | 5.1 |
| Magnetic susceptibility (χ) | -60.9×10⁻⁶ cgs |
| Viscosity | Viscous liquid |
| Dipole moment | 3.92 D |
| Pharmacology | |
| ATC code | J01DE90 |
| Hazards | |
| Main hazards | May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: H334, H317, H412 |
| Precautionary statements | Store at temperatures not exceeding 25°C. Keep out of reach of children. Avoid contact with skin and eyes. Use only as directed by a veterinarian. Dispose of unused product and waste materials in accordance with local requirements. |
| Lethal dose or concentration | LD₅₀ (mouse, intravenous): 2000 mg/kg |
| LD50 (median dose) | LD50 (median dose): >2,000 mg/kg (rat, oral) |
| NIOSH | 148852-84-0 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 2 mg/kg bw |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Cefotaxime Cefepime Ceftazidime Ceftriaxone Cefpirome |
